The Clinic Tirzepatide 30mg | Dual Agonist | Sustainable Fat Loss
GLP-1 / GIP Receptor Activation | Once-Weekly Protocol
⚡ Advanced Dual-Pathway Metabolic Control
🔥 Sustainable Fat Loss
Helps regulate appetite and reduce caloric intake for steady, controlled weight reduction.
🩸 Improved Insulin Sensitivity
Supports better blood sugar control and metabolic stability.
🎯 Craving Reduction
Assists in controlling hunger signals and emotional eating patterns.
⚙️ Enhanced Metabolic Efficiency
Promotes steady metabolic support with dual incretin receptor activation.
⏳ Long-Acting Weekly Protocol
Designed for gradual dose escalation to support tolerability and consistency.
📋 Technical Specifications:
- Compound: Tirzepatide
- Total Content: 30mg Lyophilized Peptide
- Reconstitution: 2ml Bacteriostatic Water (Included)
- Administration: Subcutaneous Injection
- Injection Sites: Abdomen, Flank, Upper Thigh
- Frequency: Once Weekly
- Cycle: Ongoing metabolic support (Review every 8–12 weeks)
📖 Titration Protocol
Week 1: 1.5mg (0.1ml)
Week 2: 3.0mg (0.2ml)
Week 3: 4.5mg (0.3ml)
Week 4: 6.0mg (0.4ml)
Typical Dose: 7.5mg (0.5ml)
Maximum Dose: 12.0mg (0.8ml)
Only increase dose if well tolerated and weight loss plateaus.
⚠️ Critical Safety Information
- Single patient use only
- Refrigerate after reconstitution (2°C – 8°C)
- Do not exceed recommended dosing protocol
- Monitor metabolic markers and overall tolerance
